Home > Boards > US Listed > Telecommunications Hardware > ADC Telecommunications (ADCT)

ADCT is doing well this AM. Top of

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
OldAIMGuy Member Profile
Member Level 
Followed By 114
Posts 14,340
Boards Moderated 7
Alias Born 01/29/02
160x600 placeholder
ADC Therapeutics participera à la conférence Jefferies London Healthcare Business Wire - 11/9/2021 2:08:00 PM
ADC Therapeutics nimmt an der Jefferies London Healthcare Conference teil Business Wire - 11/9/2021 2:08:00 PM
Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) Edgar (US Regulatory) - 11/9/2021 7:26:55 AM
ADC Therapeutics to Participate in the Jefferies London Healthcare Conference Business Wire - 11/9/2021 7:15:00 AM
ADC Therapeutics annonce des résumés qui seront présentés au 63e congrès annuel de l'ASH Business Wire - 11/5/2021 1:39:00 PM
ADC Therapeutics gibt Abstracts bekannt, die auf der 63. Jahrestagung der American Society of Hematology präsentiert werden Business Wire - 11/4/2021 6:07:00 PM
Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) Edgar (US Regulatory) - 11/4/2021 9:47:02 AM
ADC Therapeutics Announces Abstracts to be Presented at the 63rd ASH Annual Meeting Business Wire - 11/4/2021 9:25:00 AM
ADC Therapeutics gibt Finanzergebnisse für das dritte Quartal 2021 und aktuelle Unternehmensentwicklungen bekannt Business Wire - 11/4/2021 4:07:00 AM
ADC Therapeutics communique ses résultats financiers du troisième trimestre 2021 et fournit des mises à jour concernant ses activités Business Wire - 11/3/2021 3:39:00 AM
ADC Therapeutics EPS misses by $0.01, beats on revenue Seeking Alpha - 11/2/2021 7:14:07 AM
Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) Edgar (US Regulatory) - 11/2/2021 7:09:15 AM
ADC Therapeutics Reports Third Quarter 2021 Financial Results and Provides Business Updates Business Wire - 11/2/2021 7:00:00 AM
ADC Therapeutics meldet Validierung seines Antrags auf Marktzulassung von ZYNLONTA® durch die Europäische Arzneimittelagentur Business Wire - 10/29/2021 1:55:00 PM
ADC Therapeutics annonce la validation, par l'Agence européenne des médicaments, de sa demande d'autorisation de mise sur le marché de ZYNLONTA® Business Wire - 10/29/2021 12:05:00 PM
EMA validates ADC Therapeutics' lymphoma treatment Zynlonta MAA Seeking Alpha - 10/29/2021 7:28:50 AM
Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) Edgar (US Regulatory) - 10/29/2021 7:21:30 AM
ADC Therapeutics Announces Validation of its Marketing Authorization Application by the European Medicines Agency for ZYNLONTA® Business Wire - 10/29/2021 7:15:00 AM
ADC Therapeutics organisera une conférence téléphonique consacrée à ses résultats financiers du troisième trimestre le 2 novembre 2021 Business Wire - 10/27/2021 11:30:00 AM
ADC Therapeutics setzt eine Telefonkonferenz zur Besprechung der Finanzergebnisse des dritten Quartals 2021 für den 2. November 2021 an Business Wire - 10/27/2021 9:12:00 AM
ADC Therapeutics to Host Third Quarter 2021 Financial Results Conference Call on November 2, 2021 Business Wire - 10/27/2021 7:15:00 AM
Overland ADCT BioPharma gibt erste Verabreichung an Patienten in China von ZYNLONTA® im Rahmen klinischer Phase-II-Zulassungsstudie zu diffus großzelligem B-Zell-Lymphom bekannt Business Wire - 9/29/2021 5:18:00 PM
Overland ADCT BioPharma annonce la première administration à un patient de ZYNLONTA® dans le cadre d'un essai clinique pivot de Phase 2 conduit en Chine pour le traitement du lymphome diffus à grandes cellules B Business Wire - 9/29/2021 5:16:00 PM
Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) Edgar (US Regulatory) - 9/29/2021 7:23:25 AM
Overland ADCT BioPharma Announces First Patient Dosed in China with ZYNLONTA® in Pivotal Phase 2 Clinical Trial for Diffuse Large B-cell Lymphoma Business Wire - 9/29/2021 7:15:00 AM
OldAIMGuy Member Level  Wednesday, 09/11/02 01:00:35 PM
Re: None
Post # of 46 
ADCT is doing well this AM. Top of the N-100 right now - up 16%.

Best regards, Tom






Port Washington, WI 53074
Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences